Does METHYLENEDIOXYPYROVALERONE Cause Salivary hypersecretion? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Salivary hypersecretion have been filed in association with METHYLENEDIOXYPYROVALERONE. This represents 3.1% of all adverse event reports for METHYLENEDIOXYPYROVALERONE.
5
Reports of Salivary hypersecretion with METHYLENEDIOXYPYROVALERONE
3.1%
of all METHYLENEDIOXYPYROVALERONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Salivary hypersecretion From METHYLENEDIOXYPYROVALERONE?
Of the 5 reports.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLENEDIOXYPYROVALERONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLENEDIOXYPYROVALERONE Cause?
Toxicity to various agents (154)
Aggression (40)
Logorrhoea (37)
Abnormal behaviour (32)
Dysarthria (31)
Memory impairment (29)
Confusional state (19)
Coordination abnormal (19)
Disturbance in attention (19)
Restlessness (19)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which METHYLENEDIOXYPYROVALERONE Alternatives Have Lower Salivary hypersecretion Risk?
METHYLENEDIOXYPYROVALERONE vs METHYLERGONOVINE
METHYLENEDIOXYPYROVALERONE vs METHYLNALTREXONE
METHYLENEDIOXYPYROVALERONE vs METHYLPHENIDATE
METHYLENEDIOXYPYROVALERONE vs METHYLPREDNISOLONE
METHYLENEDIOXYPYROVALERONE vs METHYLPREDNISOLONE ACEPONATE